Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2004-9-22
pubmed:abstractText
Death-fold domains constitute an evolutionarily conserved superfamily that mediates apoptotic signaling. These motifs, including CARD (caspase recruitment domain), DD (death domain), and DED (death effector domain), are believed to exert their effects solely through homotypic interactions. Herein we demonstrate that the CARD-containing protein ARC engages in nontraditional death-fold interactions to suppress both extrinsic and intrinsic death pathways. The extrinsic pathway is disrupted by heterotypic interactions between ARC's CARD and the DDs of Fas and FADD, which inhibit Fas-FADD binding and assembly of the death-inducing signaling complex (DISC). The intrinsic pathway is antagonized by ARC-Bax binding, involving ARC's CARD and the Bax C terminus. This inhibits Bax activation and translocation to the mitochondria. Knockdown of endogenous ARC facilitates DISC assembly and triggers spontaneous Bax activation and apoptosis. Conversely, physiological levels of ARC suppress these events. These studies establish a critical role for nonhomotypic death-fold interactions in the regulation of apoptosis.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD95, http://linkedlifedata.com/resource/pubmed/chemical/BAX protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Bax protein, mouse, http://linkedlifedata.com/resource/pubmed/chemical/Bax protein, rat, http://linkedlifedata.com/resource/pubmed/chemical/Caspases, http://linkedlifedata.com/resource/pubmed/chemical/Death Domain Receptor Signaling..., http://linkedlifedata.com/resource/pubmed/chemical/Phenylalanine, http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-bcl-2, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Tumor Necrosis Factor, http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Fusion Proteins, http://linkedlifedata.com/resource/pubmed/chemical/bcl-2-Associated X Protein
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1097-2765
pubmed:author
pubmed:copyrightInfo
Copyright 2004 Cell Press
pubmed:issnType
Print
pubmed:day
24
pubmed:volume
15
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
901-12
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:15383280-Adenoviridae, pubmed-meshheading:15383280-Amino Acid Motifs, pubmed-meshheading:15383280-Amino Acid Substitution, pubmed-meshheading:15383280-Animals, pubmed-meshheading:15383280-Antigens, CD95, pubmed-meshheading:15383280-Apoptosis, pubmed-meshheading:15383280-Caspases, pubmed-meshheading:15383280-Cell Line, pubmed-meshheading:15383280-Cells, Cultured, pubmed-meshheading:15383280-Chromatography, Gel, pubmed-meshheading:15383280-Death Domain Receptor Signaling Adaptor Proteins, pubmed-meshheading:15383280-Humans, pubmed-meshheading:15383280-Mice, pubmed-meshheading:15383280-Models, Biological, pubmed-meshheading:15383280-Myocytes, Cardiac, pubmed-meshheading:15383280-Phenylalanine, pubmed-meshheading:15383280-Precipitin Tests, pubmed-meshheading:15383280-Protein Structure, Tertiary, pubmed-meshheading:15383280-Proto-Oncogene Proteins, pubmed-meshheading:15383280-Proto-Oncogene Proteins c-bcl-2, pubmed-meshheading:15383280-Rats, pubmed-meshheading:15383280-Receptors, Tumor Necrosis Factor, pubmed-meshheading:15383280-Recombinant Fusion Proteins, pubmed-meshheading:15383280-Two-Hybrid System Techniques, pubmed-meshheading:15383280-bcl-2-Associated X Protein
pubmed:year
2004
pubmed:articleTitle
Inhibition of both the extrinsic and intrinsic death pathways through nonhomotypic death-fold interactions.
pubmed:affiliation
Department of Medicine, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't